cdmo.directory
← Compare landing

Piramal Pharma Solutions vs WuXi XDC

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryPiramal Pharma SolutionsWuXi XDC
SummaryCDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management.WuXi XDC is a leading CRDMO offering integrated discovery, development, and cGMP manufacturing services for antibody drug conjugates (ADCs) and bioconjugates, with proximately located facilities that reduce development timelines and costs.
Services
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Controlled Substance Manufacturing
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Bioconjugation Services
  • Peptide Manufacturing
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Oral Solid Dosage Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • CMC Regulatory Submission Support
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Bioconjugation Services
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Peptide
  • Vaccine
  • Biologics (Monoclonal Antibodies)
  • Antibody-Drug Conjugate (ADC)
Development capabilities
  • Analytical method development
  • Formulation development
  • Analytical method development
  • Formulation development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Oral Solid Dose (OSD)
  • HPAPI
  • DEA licensed
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Expression: Mammalian
Locations
  • Grangemouth, Grangemouth, Scotland, United Kingdom
  • Shanghai, Shanghai, China
  • Sourcing Office, Shanghai, China
  • Headquarters, China
  • Singapore Site, Singapore, Singapore
Certifications
  • MHRA · Identifier: GMP Certificate
  • GMP · Identifier: GMP
  • ISO · Identifier: ISO 9001, 14001, 45001
  • FAMI-QS · Identifier: FAMI-QS
  • ISO · Identifier: ISO 9001
  • ISO · Identifier: ISO 14001
  • ISO · Identifier: ISO 45001
Data not yet provided.

Find similar companies

Piramal Pharma Solutions alternatives · WuXi XDC alternatives

Markdown mirror: /compare/piramalpharmasolutions/wuxi-xdc.md